187 related articles for article (PubMed ID: 28108224)
1. Effectiveness of monotherapy and combined therapy with calcitonin and minodronic acid hydrate, a bisphosphonate, for early treatment in patients with new vertebral fractures: An open-label, randomized, parallel-group study.
Tanaka S; Yoshida A; Kono S; Ito M
J Orthop Sci; 2017 May; 22(3):536-541. PubMed ID: 28108224
[TBL] [Abstract][Full Text] [Related]
2. A review of minodronic acid hydrate for the treatment of osteoporosis.
Tanishima S; Morio Y
Clin Interv Aging; 2013; 8():185-9. PubMed ID: 23440003
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of minodronic acid hydrate in patients with steroid-induced osteoporosis.
Kitamura N; Shiraiwa H; Inomata H; Nozaki T; Ikumi N; Sugiyama K; Nagasawa Y; Karasawa H; Iwata M; Matsukawa Y; Takei M
Int J Rheum Dis; 2018 Apr; 21(4):813-820. PubMed ID: 26929019
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic agents for disorders of bone and calcium metabolism: Minodronic acid hydrate].
Miki T; Minamide T
Clin Calcium; 2007 Jan; 17(1):18-22. PubMed ID: 17211089
[TBL] [Abstract][Full Text] [Related]
5. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
[TBL] [Abstract][Full Text] [Related]
6. The nature of osteoporotic low back pain without acute vertebral fracture: A prospective multicenter study on the analgesic effect of monthly minodronic acid hydrate.
Fujimoto K; Inage K; Orita S; Yamashita M; Abe K; Yamagata M; Sainoh T; Akazawa T; Kinoshita T; Nemoto T; Hirayama J; Murata Y; Kotani T; Aoki Y; Eguchi Y; Sakuma T; Aihara T; Ishikawa T; Suseki K; Hanaoka E; Yamauchi K; Kubota G; Suzuki M; Sato J; Shiga Y; Kanamoto H; Inoue M; Kinoshita H; Koda M; Furuya T; Takahashi K; Ohtori S
J Orthop Sci; 2017 Jul; 22(4):613-617. PubMed ID: 28284540
[TBL] [Abstract][Full Text] [Related]
7. Effects of 5-year treatment with elcatonin and alfacalcidol on lumbar bone mineral density and the incidence of vertebral fractures in postmenopausal women with osteoporosis: a retrospective study.
Iwamoto J; Takeda T; Ichimura S; Uzawa M
J Orthop Sci; 2002; 7(6):637-43. PubMed ID: 12486466
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacological profile and clinical efficacy of minodronic acid hydrate as a new therapeutic agent for osteoporosis].
Tanaka M; Mori H; Shimizu K; Toshiyuki ; Matsuoka ; Yamamotoya H; Minamide T; Mori M; Nozaki K; Usui T; Shimokawa K; Suzuki H; Aoyama K; Kimoto A; Sasamata M; Miyata K
Nihon Yakurigaku Zasshi; 2009 Sep; 134(3):149-57. PubMed ID: 19749488
[No Abstract] [Full Text] [Related]
9. [Minodronic acid hydrate as a new therapeutic agent for osteoporosis].
Chatani Y
Clin Calcium; 2005 Jan; 15(1):9-14. PubMed ID: 15632466
[TBL] [Abstract][Full Text] [Related]
10. Additive effect of elcatonin to risedronate for chronic back pain and quality of life in postmenopausal women with osteoporosis: a randomized controlled trial.
Hongo M; Miyakoshi N; Kasukawa Y; Ishikawa Y; Shimada Y
J Bone Miner Metab; 2015 Jul; 33(4):432-9. PubMed ID: 25123562
[TBL] [Abstract][Full Text] [Related]
11. [New development in bisphosphonate treatment. Review of the preventive effect of minodronic acid on fracture in Japanese patients with osteoporosis].
Hagino H
Clin Calcium; 2009 Jan; 19(1):75-84. PubMed ID: 19122267
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of elcatonin for alleviating pain and inhibiting bone resorption in patients with osteoporotic vertebral fractures.
Tanaka S; Yoshida A; Kono S; Oguma T; Hasegawa K; Ito M
J Bone Miner Metab; 2017 Sep; 35(5):544-553. PubMed ID: 27830386
[TBL] [Abstract][Full Text] [Related]
13. Effect of elcatonin versus nonsteroidal anti-inflammatory medications for acute back pain in patients with osteoporotic vertebral fracture: a multiclinic randomized controlled trial.
Endo N; Fujino K; Doi T; Akai M; Hoshino Y; Nakano T; Iwaya T
J Bone Miner Metab; 2017 Jul; 35(4):375-384. PubMed ID: 27465912
[TBL] [Abstract][Full Text] [Related]
14. Effect of minodronic acid hydrate on hip geometry in Japanese women with postmenopausal osteoporosis.
Ito M; Sone T; Fukunaga M
J Bone Miner Metab; 2010 May; 28(3):334-41. PubMed ID: 19937358
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled study of once weekly elcatonin in primary postmenopausal osteoporosis.
Sugimoto T; Shiraki M; Nakano T; Kishimoto H; Ito M; Fukunaga M; Sone T; Hagino H; Miki T; Nishizawa Y; Akachi S; Nakamura T
Curr Med Res Opin; 2019 Mar; 35(3):447-454. PubMed ID: 29986611
[TBL] [Abstract][Full Text] [Related]
16. Minodronic acid (ONO-5920/YM529) prevents decrease in bone mineral density and bone strength, and improves bone microarchitecture in ovariectomized cynomolgus monkeys.
Mori H; Tanaka M; Kayasuga R; Masuda T; Ochi Y; Yamada H; Kishikawa K; Ito M; Nakamura T
Bone; 2008 Nov; 43(5):840-8. PubMed ID: 18718565
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of primary osteoporosis in men].
Yamaguchi T; Sugimoto T
Clin Calcium; 2006 Mar; 16(3):474-9. PubMed ID: 16508131
[TBL] [Abstract][Full Text] [Related]
18. Effect of intermittent and daily regimens of minodronic Acid on bone metabolism in an ovariectomized rat model of osteoporosis.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Yamada H; Kawada N; Kawabata K
Calcif Tissue Int; 2014 Aug; 95(2):166-73. PubMed ID: 24903232
[TBL] [Abstract][Full Text] [Related]
19. Zoledronic acid infusion for lumbar interbody fusion in osteoporosis.
Tu CW; Huang KF; Hsu HT; Li HY; Yang SS; Chen YC
J Surg Res; 2014 Nov; 192(1):112-6. PubMed ID: 24948545
[TBL] [Abstract][Full Text] [Related]
20. [New development in bisphosphonate treatment. Review of effect on bone metabolism by minodronic acid in primary osteoporosis].
Fukunaga M
Clin Calcium; 2009 Jan; 19(1):63-73. PubMed ID: 19122266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
